Hydrocortisone Hemisuccinate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

84 API Suppliers, 29 USDMF, 14 CEP/COS, 6 JDMF, 9 EU WC, 10 KDMF, 40 NDC API, 1 VMF, 33 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

60 Drugs in Development

60 Drugs in Development

FINISHED DOSAGE FORMULATIONS

457 FDF Dossiers, 235 FDA Orange Book, 152 Europe, 11 Canada, 8 Australia, 28 South Africa, 23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OTIC - EQ 0.2% BASE;1%, CREAM;TOPICAL - 5%;1%, OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 1%, LOTION;TOPICAL - 2%, TABLET;ORAL - 10MG, TABLET;ORAL - 20MG, TABLET;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 Rochem International Inc, 8 SPI Pharma, 17 DKSH, 1 Pharm-RX Chemical, 6 Gangwal Healthcare, 24 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 4 Pfanstiehl, 23 Kirsch Pharma, 22 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 42 BASF, 3 BioSpectra, 4 CD Formulation, 1 Clariant, 15 Corel Pharma Chem, 7 DFE Pharma, 3 Esteem Industries, 6 Finar, 16 Gangwal Chemicals, 2 Hayashibara, 2 Ideal Cures, 4 Ingredion Pharma Solutions, 19 Kerry, 3 Keval Exports, 9 Lubrizol Life Science Health, 17 Microlex e.U, 3 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 33 Roquette, 21 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 5 Silverline Chemicals, 1 Symrise, 2 Valens Pharmachem, 5 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

92 Topical, 64 Thickeners and Stabilizers, 60 Solubilizers, 59 Parenteral, 57 Fillers, Diluents & Binders, 36 Direct Compression, 33 Granulation, 33 Emulsifying Agents, 28 Lubricants & Glidants, 27 Coating Systems & Additives, 27 Disintegrants & Superdisintegrants, 23 Controlled & Modified Release, 23 Surfactant & Foaming Agents, 20 Film Formers & Plasticizers, 18 Taste Masking, 14 Co-Processed Excipients, 12 Chewable & Orodispersible Aids, 10 Rheology Modifiers, 6 API Stability Enhancers, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 49 News #PharmaBuzz

GLOBAL SALES INFORMATION

38 US Medicaid Prescriptions, 77 Regulatory FDF Prices, 1 Annual Reports

MARKET PLACE

35 APIs, 17 FDF Dossiers

PATENTS & EXCLUSIVITIES

14 US Patents, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 3 JP, 27 Others

ANALYTICAL

2 BioAnalytical Methods, 4 Analytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 50168 / DOSAGE - OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
BACITRACIN ZINC(UNII: 89Y4M234ES) (BACITRACIN - UNII:58H6RWO52I)	BACITRACIN	400[iU] in 1
HYDROCORTISONE(UNII: WI4X0X7BPJ) (HYDROCORTISONE - UNII:WI4X0X7BPJ)	HYDROCORTISONE	10mg in 1
NEOMYCIN SULFATE(UNII: 057Y626693) (NEOMYCIN - UNII:I16QD7X297)	NEOMYCIN	3.5mg in 1
POLYMYXIN B SULFATE(UNII: 19371312D4) (POLYMYXIN B - UNII:J2VZ07J96K)	POLYMYXIN B	5000[iU] in 1

Inactive Ingredients

Ingredient Name	Pfizer Laboratories Div Pfizer Inc
PETROLATUM(4T6H12BN9U)

Setid 097a7a8d 04d4 4736 C8b7 0796117457bf Applno 50168 Form Ointment Topical Dosage 400 Units Gm 1 Eq 3 5mg Base Gm 5 000 Units Gm - Drug Product Composition: Hydrocortisone Hemisuccinate